31.65000 TWD
0.25
0.78%
Last update Dec 16, 1:21 PM CST
Market closed
Day range
31.5
32.15000
Previous close
31.90000
Open
32.099998
Access this stock data via API
Subscribe
Mycenax Biotech Inc.
31.65
0.25
0.78%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 131.4M 202.6M 121.7M 194.0M
Cost of revenue 196.6M 245.2M 200.2M 229.3M
Gross profit -65.3M -42.7M -78.5M -35.3M
Operating expense
Research & development 19.5M 19.0M 17.5M 22.7M
Selling general and admin 38.7M 39.3M 32.1M 33.7M
Other operating expenses
Operating income -123.4M -100.9M -128.1M -91.7M
Non operating interest income
Income 126K 1.5M 343K 3.1M
Expense 8.2M 8.1M 7.8M 7.7M
Other income expense
Pretax income -128.0M -140.3M -130.2M -90.6M
Tax provision 1.9M -3.1M -1.0M -7.4M
Net income -129.9M -137.2M -129.1M -83.3M
Basic EPS -0.6 -0.7 -0.6
Diluted EPS -0.6 -0.7 -0.6
Basic average shares 206.2M 207.8M 207.0M
Diluted average shares 206.2M 207.8M 207.0M
EBITDA -47.8M -62.9M -49.4M -9.5M
Net income from continuing op. -128.0M -140.3M -130.2M -90.6M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 hours 39 minutes

21:20
00:00
09:00
13:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 13:30
All times are displayed in the Asia/Taipei timezone (CST, UTC+08:00).